
Cfo-T Injection
Marketer
Wohltat Lifesciences
Salt Composition
Cefoperazone (1000mg) + Tazobactum (125mg)
Overview Cfo-T Injection
Cfo-T Injection combines multiple medications to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must always be overseen by a medical professional. Consistent adherence to the prescribed dosage schedule is crucial; premature cessation risks treatment efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications before commencing treatment. Expectant or lactating mothers should consult their doctor prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Rest, a nutritious diet, and adequate hydration will promote recovery. Your physician may order blood work and other tests to monitor treatment response.
Primary Ingredients of Cfo-T Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Cfo-T Injection
Combating Bacterial Infections
Major Benefits of Cfo-T Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cfo-T Injection:
- Diarrhea
- Abnormal liver function tests
- Allergic reaction
- Anemia (low number of red blood cells)
How to use Cfo-T Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cfo-T Injection works:
Cfo-T Injection merges Cefoperazone, a bacterial growth inhibitor, and Tazobactum, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counters bacterial resistance mechanisms, thereby improving Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Cfo-T Injection can result in adverse effects including facial redness, tachycardia, nausea, thirst, chest discomfort, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
Administration of Cfo-T Injection during pregnancy is typically regarded as safe. Preclinical trials using animal models have revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Cfo-T Injection poses no known breastfeeding risks. Research in humans indicates minimal drug transfer to breast milk, presenting no apparent danger to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Cfo-T Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cfo-T Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cfo-T Injection to individuals with hepatic impairment. Seek medical advice from your physician.
What if you forget to take Cfo-T Injection :
Omit a Cfo-T Injection dose? Seek your physician's advice.
Facts to Know About Cfo-T Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
